PREVIOUS
✖
Bharat Biotech's TB vaccine
March 30 , 2024
243 days
329
0
- Bharat Biotech, based in Hyderabad, has started clinical trials of MTBVAC.
- This is the world's first Mycobacterium tuberculosis vaccine derived from a human source, in India.
- It is being developed by Spanish biopharma player Biofabri in collaboration with Bharat Biotech.
- MTBVAC is being developed as a more effective and potentially longer-lasting vaccine than BCG vaccine, that is over 100 years old.
Leave a Reply
Your Comment is awaiting moderation.